Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Schumer calls on Leland Dudek, acting commissioner of SSA, to resign

Related Posts

Pam Bondi already fired as attorney general, Cabinet...

April 3, 2026

Pro-life father whose home FBI raided appeals ruling...

April 19, 2025

Putin ‘doesn’t want peace,’ EU chief diplomat warns...

February 28, 2025

Iran says it has ‘plenty of scientists’ left...

August 2, 2025

Supreme Court must freeze the climate extortion of...

October 1, 2025

South African-born Musk evoked by Trump during meeting...

May 22, 2025

Israel’s military will remain in Lebanon as ceasefire...

January 25, 2025

Fetterman dismisses questions as another top staffer reportedly...

June 4, 2025

‘Truly providential’: Trump made promise to Marc Fogel’s...

February 14, 2025

Trump declines to commit to two-state solution after...

October 14, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved